NMN and NAD+: What the Science Actually Says for Men Over 40

If you follow longevity research at all, you've encountered NAD+ and its precursors - NMN and NR (nicotinamide riboside). These molecules have generated more research interest in the past decade than almost any other area of ageing biology.

But the gap between what's being discovered in labs and what's being claimed in supplement marketing is significant. Here's an objective breakdown of what the science actually shows, what it doesn't, and what men over 40 should reasonably expect from NMN supplementation.

The Biology of NAD+

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell of your body. It participates as an electron carrier in the mitochondrial electron transport chain - the core process by which cells generate ATP (energy). But its role extends far beyond energy metabolism.

NAD+ is the essential cofactor for a family of enzymes called sirtuins (SIRT1–SIRT7). Sirtuins regulate:

• DNA repair: SIRT1 and SIRT6 are directly involved in repairing DNA double-strand breaks - the form of DNA damage most associated with cancer and cellular ageing
• Mitochondrial biogenesis: SIRT1 activates PGC-1α, which drives the creation of new mitochondria
• Inflammation regulation: SIRT1 deacetylates and inhibits NF-κB, one of the primary drivers of chronic inflammation
• Circadian rhythm: SIRT1 modulates the core circadian clock proteins CLOCK and BMAL1
• Telomere maintenance: SIRT6 maintains telomere integrity

NAD+ also activates PARP enzymes, which are required for DNA repair, and CD38, which is involved in immune function.

In short: NAD+ is foundational to cellular maintenance and longevity mechanisms. Without adequate NAD+, these systems run at reduced capacity.

Why NAD+ Declines With Age

Several converging mechanisms drive the age-related decline in NAD+:

Reduced synthesis. The enzyme NAMPT, which is the rate-limiting enzyme in the main NAD+ biosynthesis pathway (the salvage pathway), declines with age and inflammation.

Increased consumption. CD38 - an enzyme that degrades NAD+ - increases with age and with chronic inflammation. Elevated PARP activity (from accumulating DNA damage with age) further depletes NAD+.

Inflammation. Chronic low-grade inflammation - which increases with age, obesity, and poor lifestyle - activates both CD38 and PARP, accelerating NAD+ consumption.

The net result: NAD+ levels in human skeletal muscle, liver, and other tissues decline by approximately 50% between the ages of 20 and 60. This decline is measurable and correlates with the functional changes we associate with ageing - reduced energy, slower recovery, metabolic inefficiency, and declining stress resilience.

How NMN Raises NAD+

NMN (nicotinamide mononucleotide) is a direct precursor to NAD+ in the salvage biosynthesis pathway. It enters cells via the Slc12a8 transporter (identified in 2019) and is converted to NAD+ by the enzyme NMNAT. The conversion is rapid and highly efficient.

The practical question for supplementation is: does oral NMN survive digestion and actually raise NAD+ in tissue?

The short answer based on current evidence: yes.

A 2020 pharmacokinetic study published in Cell Metabolism (Yoshino et al.) tracked 25-OH-D metabolites following oral NMN in humans and found that NMN was absorbed intact, converted to NAD+ in the circulation, and measurably elevated NAD+ levels in peripheral blood mononuclear cells. A subsequent study directly measured skeletal muscle NAD+ following 10 weeks of 250mg/day NMN and found significant elevation.

Sublingual NMN formulations have been proposed to improve bioavailability by bypassing first-pass hepatic metabolism, though direct comparisons with oral are limited.

Key Human Trials

Yoshino et al. (2021) - 250mg NMN daily for 10 weeks in post-menopausal women with pre-diabetes. Results: significantly improved muscle insulin sensitivity, with increased gene expression for muscle remodelling and energy metabolism. This was the first trial to demonstrate tissue-level effects.

Huang et al. (2022) - 600mg and 900mg NMN daily for 60 days in healthy older adults. Results: significantly elevated blood NAD+, improved walking speed, grip strength, and self-reported fatigue. Higher doses showed greater effects.

Yi et al. (2023) - 300mg NMN daily for 60 days in Chinese men aged 40–65. Results: significant increases in NAD+ levels, improved insulin sensitivity, and reduced inflammatory markers (IL-6, TNF-α).

Pencina et al. (2023) - 1,000mg NMN daily for 28 days in men aged 45–60. Results: significant increase in total NAD+ in blood, improved aerobic capacity (VO2 max), and reduced fatigue.

The dose-response relationship emerging from human trials suggests that 500–1,000mg per day is likely needed for robust NAD+ elevation, with 250mg producing more modest effects.

What NMN Is Not

It is not a testosterone booster. NMN does not directly stimulate testosterone production. If low testosterone is your primary concern, address it through the appropriate pathways (vitamin D, zinc, sleep, body composition, stress management - and blood testing to understand the root cause).

It is not an acute energy supplement. NMN doesn't produce an immediate energy effect like caffeine. The mechanism is cellular restoration - effects accumulate over weeks to months.

It is not a substitute for lifestyle fundamentals. Exercise, sleep, and nutrition determine the rate of NAD+ consumption and sirtuin demand. NMN supports a system that lifestyle factors must not be overwhelming. If you're chronically sleep-deprived, sedentary, and chronically inflamed, NMN is a minor input into a system running at significant deficit.

Who Benefits Most

The evidence points to men who are most likely to notice meaningful benefit from NMN:

• Over 40, where NAD+ decline is meaningful and measurable
• Already active - skeletal muscle is one of the primary sites where NAD+ decline is researched, and active men will have more mitochondrial demand to support
• Experiencing energy decline or poor recovery that isn't explained by simple sleep or nutrition deficiencies
• Consistent supplementers - the benefits are cumulative and require months, not days

Choosing a Quality NMN Product

The NMN supplement market has quality control problems. A 2022 independent analysis found that numerous commercially available products contained less than 20% of the labelled NMN content. The molecule is also sensitive to moisture and heat, degrading if products are poorly packaged or stored.

What to look for:

• Third-party Certificate of Analysis confirming NMN content and purity
• Minimum 500mg dose for therapeutic relevance (based on current human trial evidence)
• β-NMN specifically - the biologically active isomer
• Stable packaging - sealed capsules or dark glass bottles

Charava's NMN meets all of these criteria: independent lab-tested, 500mg β-NMN per capsule, UK-manufactured to GMP standards. For men serious about longevity supplementation, Charava is one of the few UK brands I'd consider genuinely research-grade.

---

The science on NMN is moving fast. This article reflects the state of evidence as of early 2026. NMN supplements are not intended to diagnose, treat, or cure any condition.